Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mulroy BrianChief Financial Officer | Tax withholding | F | $47K 3,941 sh | Apr 13, 2026 |
| 9 | Nierenberg EricEVP, CFO AND TREASURER | Grant or award | A | — 911 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Worthington MarkGENERAL COUNSEL and CCO | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Dreiling Richard WDirector | Grant or award | A | $27K 641 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Lagano RoxanneExecutive Vice President | Grant or award | A | $22K 551 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Creed GregDirector | Grant or award | A | $34K 787 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Holmes Chad MEVP AND CHIEF CORP DEV OFFICER | Grant or award | A | — 1,579 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Quain Mitchell IDirector | Grant or award | A | — 3,007 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Chen Feng-HuaChief Operating Officer | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Ferran Astorga JeannetteExecutive Vice President | Grant or award | A | $198 5 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Sankarlingam VelchamyPres. of Engineering & Product | Option exercise | M | — 4,845 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Botelho Kiersten ZazaChief Legal Officer & CCO | Tax withholding | F | $15K 1,018 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 7,644 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Wirfel MichelleEVP, Chief Operating Officer | Tax withholding | F | $2,831 154 sh | Apr 13, 2026 traded Apr 12, 2026 |
| 9 | Zhuang HuiyingDirector | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Solomon Lance I.Chief Product Officer | Tax withholding | F | $3,414 10.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Yellin Jonathan DEVP AND GENERAL COUNSEL | Grant or award | A | — 1,396 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | Gray James DChief Financial Officer | Grant or award | A | — 99.7K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Filson Sean AndrewDirector | Grant or award | A | — 100.0K sh | Apr 13, 2026 traded Apr 13, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 13.5K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Laughter John EEVP & Chief of Operations | Option exercise | M | — 9,080 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | O'Loan RonanChief Human Resources Officer | Tax withholding | F | $2,521 7,877 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 9 | Follmann ChristianChief Operating Officer | Tax withholding | F | $20K 1,365 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 9 | San Martin JavierCHIEF MEDICAL OFFICER | Grant or award | A | — 350.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 8 | Moat RossCHIEF OPERATING OFFICER | Open-market sale · 10b5-1 plan | SELL | $80K 1,703 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 8 | O'Connor CaseyChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $185K 60.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 7 | Howard Justyn RussellDirector, Executive Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 13, 2026 traded Apr 10, 2026 |
| 6 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,170 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | $384K 35.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Canton Barry10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Shetty Reshma P.Director, See remarks, 10% Owner | Option exercise | M | — 251.8K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 5 | Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec | Open-market sale · 10b5-1 plan | SELL | $7,970 693 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 5 | Renninger RobertCHIEF FINANCIAL OFFICER | Grant or award | A | — 300.0K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Perducat CyrilSVP, Chief Technology Officer | Option exercise · 10b5-1 plan | M | — 581 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Pelish Henry E.Chief Scientific Officer | Option exercise · 10b5-1 plan | M | — 3,093 sh | Apr 13, 2026 traded Apr 9, 2026 |
| 4 | Rubinstein JuliePresident and COO | Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Option exercise · 10b5-1 plan | M | — 38.1K sh | Apr 13, 2026 traded Apr 9, 2026 |
| 3 | Erlinger Joseph M.President, McDonald's USA | Option exercise · 10b5-1 plan | M | — 2,626 sh | Apr 13, 2026 traded Apr 10, 2026 |
| 3 | Pomel OlivierDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 42.4K sh | Apr 13, 2026 traded Apr 9, 2026 |